Last reviewed: June 20, 2026
Last updated: June 20, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic contains semaglutide, a synthetic compound that activates GLP-1 receptors—the same pathway natural appetite-regulating peptides use in your body. While Ozempic itself isn't a peptide, it works like one, making the distinction mostly technical. Understanding this difference matters when exploring affordable alternatives for weight loss and metabolic health.
What Exactly Is Ozempic and How Does It Work
Ozempic is a prescription medication containing semaglutide, manufactured by Novo Nordisk. Semaglutide is not a peptide but rather a small organic compound designed to mimic the action of glucagon-like peptide-1 (GLP-1), a natural hormone your intestines release after eating. When semaglutide binds to GLP-1 receptors on cells throughout your brain, pancreas, and digestive system, it slows stomach emptying, increases feelings of fullness, and helps regulate blood sugar levels.
The FDA approved Ozempic in 2017 for type 2 diabetes management, and later approved the higher-dose version Wegovy in 2021 for chronic weight management in adults with obesity or overweight with weight-related conditions. Clinical trials showed participants lost 5–15% of their body weight over 68 weeks depending on the dose. The medication has become widely prescribed off-label for weight loss, driving demand and creating supply shortages that have affected patient access and insurance coverage.
Peptides vs. GLP-1 Agonists: Understanding the Chemistry
Peptides are chains of amino acids, and true peptide GLP-1 agonists do exist—the original GLP-1 hormone is itself a peptide with 30 amino acids. However, semaglutide (the active ingredient in Ozempic and Wegovy) is a non-peptide small molecule with a longer half-life and better oral bioavailability than natural GLP-1. This chemical modification allows semaglutide to stay in your bloodstream longer and work more effectively across different tissues.
Tirzepatide, another popular GLP-1 receptor agonist found in Mounjaro and Zepbound, is also a non-peptide compound. Both semaglutide and tirzepatide achieve weight loss and metabolic benefits by triggering the same GLP-1 signaling pathways that peptide hormones naturally activate, making the peptide-versus-agonist distinction less important clinically than efficacy and individual response.
Why Compounded Semaglutide May Be Right for You
PlexusDx partners with licensed 503A compounding pharmacies to provide compounded semaglutide injections starting at $149 per month—significantly lower than brand-name Ozempic, which often costs $900–$1,300 per month before insurance. Compounded semaglutide contains the same active ingredient as Ozempic but is prepared by licensed pharmacists rather than mass-manufactured by a pharmaceutical company. Both forms activate GLP-1 receptors identically and produce comparable weight loss outcomes in clinical use.
PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays. Your dose may need to increase over time as your body builds tolerance, but your monthly price remains flat—never scaling with dosage adjustments. HSA and FSA accounts are accepted, offering additional tax-advantaged savings on your treatment.
Personalized Treatment: The Precision Peptide Genetic Test Advantage
Not everyone responds equally to GLP-1 agonists. Your genetic makeup influences how effectively semaglutide engages GLP-1 receptors and how your body processes the medication. PlexusDx offers the Precision Peptide Genetic Test, a $99 add-on after your first month of treatment, which analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 across 14 metabolic pathways.
This test maps your peptide-pathway genetics to 150+ personalized insights, helping PlexusDx clinicians predict your likely response to semaglutide and recommend optimal dosing strategies. Patients with certain GLP1R variants may experience superior appetite suppression at standard doses, while others benefit from carefully graduated increases. Genetic insights empower you to avoid dose-escalation frustration and maximize your weight loss results from day one.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic technically a peptide shot?
No—Ozempic contains semaglutide, a non-peptide small molecule that mimics the action of GLP-1, a natural peptide hormone. While not a peptide itself, semaglutide activates the same GLP-1 receptors that peptide signaling does, making the distinction mostly chemical rather than functional.
How does compounded semaglutide from PlexusDx compare to brand-name Ozempic?
Compounded semaglutide from PlexusDx is prepared by licensed 503A pharmacies and contains the identical active ingredient as Ozempic. The main differences are cost (starting at $149/month vs. $900–$1,300 for Ozempic) and convenience—no insurance required, no authorization delays, and nationwide availability.
Why does my GLP-1 dose need to increase over time?
Your body adapts to medications through a process called tachyphylaxis, reducing the drug's initial effect. GLP-1 therapy typically begins at low doses and gradually increases every 4 weeks until you reach your therapeutic dose or experience optimal appetite suppression. PlexusDx keeps your monthly price flat throughout this escalation—your dose goes up, your price won't.
What side effects should I expect from semaglutide injections?
Common side effects include mild nausea, vomiting, diarrhea, and constipation, especially during the first 2–4 weeks. Most side effects diminish as your body adjusts. Serious side effects are rare but include pancreatitis (severe abdominal pain) and gallbladder issues. Always report persistent symptoms to your PlexusDx clinician.
How does the Precision Peptide Genetic Test improve my treatment outcomes?
The test identifies your genetic predispositions across 14 peptide pathways and 49 metabolic peptides, revealing how your body will likely respond to semaglutide dosing. This guides clinicians to optimize your starting dose and escalation schedule, potentially accelerating weight loss and reducing the trial-and-error phase of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimal Nutrition: What Foods to Eat While Taking Wegovy for Lasting Success
Understanding the Starting Dose of Zepbound for Effective Weight Management